Insider Trading Alert - BZH, SPA And TIPT Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 9, 2015, 56 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $95.26 to $84,834,000.00.

Highlighted Stocks Traded by Insiders:

Beazer Homes USA (BZH) - FREE Research Report

Zelnak Stephen P Jr, who is Director at Beazer Homes USA, bought 10,000 shares at $15.63 on Feb. 9, 2015. Following this transaction, the Director owned 61,261 shares meaning that the stake was boosted by 19.51% with the 10,000-share transaction.

The shares most recently traded at $16.77, up $1.14, or 6.81% since the insider transaction. Historical insider transactions for Beazer Homes USA go as follows:

  • 4-Week # shares bought: 17,500
  • 12-Week # shares bought: 17,500
  • 24-Week # shares bought: 17,500

The average volume for Beazer Homes USA has been 716,300 shares per day over the past 30 days. Beazer Homes USA has a market cap of $436.2 million and is part of the industrial goods sector and materials & construction industry. Shares are down 14.77% year-to-date as of the close of trading on Monday.

Beazer Homes USA, Inc. designs, builds, and sells single-family and multi-family homes in the United States. It provides homes for entry-level, move-up, or retirement-oriented buyers. The company has a P/E ratio of 27.4. Currently, there are 3 analysts who rate Beazer Homes USA a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BZH - FREE

TheStreet Quant Ratings rates Beazer Homes USA as a sell. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself, unimpressive growth in net income, generally high debt management risk, poor profit margins and weak operating cash flow. Get the full Beazer Homes USA Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Sparton (SPA) - FREE Research Report

Swartwout James R, who is Director at Sparton, bought 1,000 shares at $22.00 on Feb. 9, 2015. Following this transaction, the Director owned 35,074 shares meaning that the stake was boosted by 2.93% with the 1,000-share transaction.

Fast James D, who is Director at Sparton, bought 500 shares at $22.26 on Feb. 9, 2015. Following this transaction, the Director owned 32,663 shares meaning that the stake was boosted by 1.55% with the 500-share transaction.

Pearson Donald W, who is Sr. VP & CFO at Sparton, bought 3,000 shares at $21.76 on Feb. 9, 2015. Following this transaction, the Sr. VP & CFO owned 18,000 shares meaning that the stake was boosted by 20% with the 3,000-share transaction.

The shares most recently traded at $22.50, up $0.74, or 3.29% since the insider transaction. Historical insider transactions for Sparton go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 9,007
  • 12-Week # shares bought: 2,000
  • 12-Week # shares sold: 9,007
  • 24-Week # shares bought: 2,000
  • 24-Week # shares sold: 30,000

The average volume for Sparton has been 65,400 shares per day over the past 30 days. Sparton has a market cap of $218.4 million and is part of the technology sector and electronics industry. Shares are down 20.89% year-to-date as of the close of trading on Monday.

Sparton Corporation, together with its subsidiaries, is engaged in the concept development, design and manufacturing engineering, production, distribution, and field service of electromechanical devices in the United States and internationally. The company has a P/E ratio of 25.1. Currently, there is 1 analyst who rates Sparton a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SPA - FREE

TheStreet Quant Ratings rates Sparton as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Sparton Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Tiptree Financial (TIPT) - FREE Research Report

Barnes Michael Gene, who is Executive Chairman at Tiptree Financial, bought 1,730 shares at $7.49 on Feb. 9, 2015. Following this transaction, the Executive Chairman owned 1.1 million shares meaning that the stake was boosted by 0.16% with the 1,730-share transaction.

The shares most recently traded at $7.48, down $0.01, or 0.16% since the insider transaction.

The average volume for Tiptree Financial has been 20,100 shares per day over the past 30 days. Tiptree Financial has a market cap of $235.2 million and is part of the financial sector and insurance industry. Shares are down 8.77% year-to-date as of the close of trading on Monday.

TipTree Financial Inc., formerly Care Investment Trust, operates as a real estate investment trust (REIT). It engages in originating and acquiring healthcare-related real estate and commercial mortgage debt.

Exclusive Offer: Get the latest Stock Analysis on TIPT - FREE

TheStreet Quant Ratings rates Tiptree Financial as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, generally high debt management risk, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full Tiptree Financial Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Markets Push Higher Following Fed Chair's First Testimony on Capitol Hill

Markets Push Higher Following Fed Chair's First Testimony on Capitol Hill

Nasdaq Hits Intraday High Despite Netflix's Whiff

Nasdaq Hits Intraday High Despite Netflix's Whiff

Goldman Shares Slump on Outlook Worries as Profit Jumps 40%

Goldman Shares Slump on Outlook Worries as Profit Jumps 40%

UnitedHealth's Beat Wasn't Clean, Says Analysts

UnitedHealth's Beat Wasn't Clean, Says Analysts

Depositors Stiffed as Bank of America Reaps Windfall From Taxes, Rates

Depositors Stiffed as Bank of America Reaps Windfall From Taxes, Rates